Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,370,632 papers from all fields of science
Search
Sign In
Create Free Account
darusentan
Known as:
(+)-(S)-2-((4,6-dimethoxy-2-pyrimidinyl)oxy)-3-methoxy-3,3-diphenylpropionic acid
, benzenepropanoic acid, alpha-((4,6-dimethoxy-2-pyrimidinyl)oxy)-beta-methoxy-beta-phenyl-, (S)-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (3)
Endothelin receptor antagonist
Phenylpropionates
Pyrimidines
Narrower (1)
LU 135252
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Endothelin receptor antagonists in proteinuric renal disease: every rose has its thorn.
E. Ritz
,
R. Wenzel
Journal of the American Society of Nephrology
2010
Corpus ID: 38590775
When Yanagisawa et al. 1 first identified endothelin (ET), a novel polypeptide vasoconstrictor for which numerous other functions…
Expand
2008
2008
Efficacy and Safety of Darusentan: A Novel Endothelin Receptor Antagonist
B. Epstein
The Annals of Pharmacotherapy
2008
Corpus ID: 12779533
Objective: To summarize the role of the endothelin system (ETS) in cardiovascular disease (CVD) and evaluate the potential…
Expand
2008
2008
Endothelin receptor antagonism: what does the future hold?
D. Sica
HYPERTENSION
2008
Corpus ID: 18410054
The endothelins are a family (ET-1, ET-2, and ET-3) of naturally occurring polypeptides, with ET-1 being the most clinically…
Expand
2006
2006
Spironolactone preserves cardiac norepinephrine reuptake in salt-sensitive Dahl rats.
S. Buss
,
J. Backs
,
+4 authors
M. Haass
Endocrinology
2006
Corpus ID: 16904387
An impairment of cardiac norepinephrine (NE) reuptake via the neuronal NE transporter (NET) enhances the effects of increased…
Expand
2003
2003
Effects of the Endothelin A Receptor Antagonist Darusentan on Blood Pressure and Vascular Contractility in Type 2 Diabetic Goto-Kakizaki Rats
K. Witte
,
Ina Reitenbach
,
Kerstin Stolpe
,
L. Schilling
,
M. Kirchengast
,
B. Lemmer
Journal of Cardiovascular Pharmacology
2003
Corpus ID: 25156462
The present study evaluated the effects of long-term treatment with the endothelin A (ETA) receptor antagonist darusentan…
Expand
2003
2003
Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension
L. Rothermund
,
P. Kossmehl
,
H. Neumayer
,
M. Paul
,
R. Kreutz
Journal of Hypertension
2003
Corpus ID: 45167835
Objective Secondary activation of the renin–angiotensin system plays a major role in the progression of chronic nephropathies…
Expand
2002
2002
Endothelin A-receptor antagonist administration immediately after experimental myocardial infarction with reperfusion does not affect scar healing in dogs.
C. Basso
,
G. Thiene
,
M. della Barbera
,
A. Angelini
,
M. Kirchengast
,
S. Iliceto
Cardiovascular Research
2002
Corpus ID: 32705156
Highly Cited
2002
Highly Cited
2002
Pharmacological prevention and regression of arterial remodeling in a rat model of isolated systolic hypertension
H. H. Dao
,
Rachida Essalihi
,
Jean-François Graillon
,
R. Lariviere
,
J. de Champlain
,
P. Moreau
Journal of Hypertension
2002
Corpus ID: 43854427
Objectives and design Isolated systolic hypertension (ISH) is the predominant form of hypertension in the elderly population and…
Expand
2002
2002
Effects of obesity on endothelium-dependent reactivity during acute nitric oxide synthase inhibition: modulatory role of endothelin.
T. Traupe
,
L. d’Uscio
,
K. Muenter
,
H. Morawietz
,
W. Vetter
,
M. Barton
Clinical science
2002
Corpus ID: 13134762
This study investigated vascular reactivity in response to acetylcholine, in the presence of acute inhibition of nitric oxide…
Expand
Highly Cited
2001
Highly Cited
2001
Norepinephrine-induced aortic hyperplasia and extracellular matrix deposition are endothelin-dependent
H. H. Dao
,
Jacinthe Lemay
,
J. Champlain
,
D. Deblois
,
P. Moreau
Journal of Hypertension
2001
Corpus ID: 39944131
Background Sympathetic hyperactivity is observed in several disease states and may contribute to cardiovascular hypertrophic…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE